Recombinant production platform for Group A Streptococcus glycoconjugate vaccines.

Saved in:
Bibliographic Details
Title: Recombinant production platform for Group A Streptococcus glycoconjugate vaccines.
Authors: Ajay Castro S; Division of Molecular Microbiology, School of Life Sciences, Dundee, United Kingdom., Passmore IJ; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom., Ndeh D; Division of Molecular Microbiology, School of Life Sciences, Dundee, United Kingdom., Shaw HA; The Medicines and Healthcare products Regulatory Agency (MHRA), Vaccines Division, Scientific Research & Innovation Group, London, United Kingdom., Ruda A; Department of Organic Chemistry, Stockholm University, Stockholm, Sweden., Burns K; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.; The Medicines and Healthcare products Regulatory Agency (MHRA), Vaccines Division, Scientific Research & Innovation Group, London, United Kingdom., Thomson S; Biological Services, School of Life Sciences, University of Dundee, Dundee, United Kingdom., Nagar R; Division of Molecular Microbiology, School of Life Sciences, Dundee, United Kingdom., Alagesan K; Max Planck Unit for the Science of Pathogens, Berlin, Germany., Reglinski M; Division of Molecular Microbiology, School of Life Sciences, Dundee, United Kingdom., Lucas K; Division of Molecular Microbiology, School of Life Sciences, Dundee, United Kingdom., Abouelhadid S; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom., Schwarz-Linek U; Biomedical Sciences Research Complex, University of St. Andrews, Fife, United Kingdom., Mawas F; The Medicines and Healthcare products Regulatory Agency (MHRA), Vaccines Division, Scientific Research & Innovation Group, London, United Kingdom., Widmalm G; Department of Organic Chemistry, Stockholm University, Stockholm, Sweden., Wren BW; Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom. brendan.wren@lshtm.ac.uk., Dorfmueller HC; Division of Molecular Microbiology, School of Life Sciences, Dundee, United Kingdom. hczdorfmueller@dundee.ac.uk.
Source: NPJ vaccines [NPJ Vaccines] 2025 Jan 22; Vol. 10 (1), pp. 16. Date of Electronic Publication: 2025 Jan 22.
Publication Type: Journal Article
Journal Info: Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2059-0105
DOI:10.1038/s41541-025-01068-2